Drägerwerk AG & Co. KGaA

  • WKN: 555060
  • ISIN: DE0005550602
  • Land: Deutschland

Nachricht vom 12.04.2019 | 13:13

Drägerwerk AG & Co. KGaA: preliminary result for the first quarter. Net sales and earnings with significant rise over the prior year's figures.

Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results
Drägerwerk AG & Co. KGaA: preliminary result for the first quarter. Net sales and earnings with significant rise over the prior year's figures.

12-Apr-2019 / 13:13 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc notification in accordance with Sec. 17 of the MAR

Drägerwerk AG & Co. KGaA: preliminary result for the first quarter. Net sales and Earnings with significant rise over the prior year's figures.

Order intake in the first quarter rose by roughly 3.4 percent net of currency effects (nominal: 4.2 percent) compared to the first quarter last year. Compared to the prior year's quarter, all regions increased order intake. Demand increase was strongest in the Americas region.
From the product perspective, order intake was particularly strong for safety products, while order intake for medical products contracted.

Net sales increased by roughly 20.7 percent net of currency effects (nominal: 21.4 percent) to approximately EUR 602 million. Net sales increased in all three regions in medical, as well as in safety. The gross profit margin stood at roughly 42.3 percent (Q1 2018: 41.4 percent). Functional expenses increased by 7.3 percent net of currency effects (nominal: 8.2 percent). EBIT for the first quarter amounted to roughly EUR -11 million (Q1 2018: EUR -39.8 million), which corresponds to an EBIT-margin of roughly -1.8 %.

Net sales and earnings are therefore significantly above the prior year's figures. In the prior year's quarter exceptional delivery delays had burdened the net sales development.

For the full year, Draeger continues to expect net sales growth (net of currency effects) of between 1.0 and 4.0 percent and an EBIT-margin of between 1.0 and 3.0 percent.

Dräger will publish final results for the first three months on April 25, 2019.

Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Deutschland
www.draeger.com

Investor Relations:
Thomas Fischler
Tel. +49 451 882-2685
thomas.fischler@draeger.com

Corporate Communications:
Melanie Kamann
Tel. +49 451 882-3998
melanie.kamann@draeger.com

Disclaimer
This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.


12-Apr-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Media and Games Invest wächst dynamisch und profitabel

Innerhalb des Konzerns Media and Games Invest sind der wachstumsstarke Game-Publisher gamigo AG sowie Unternehmen aus dem dynamischen Bereich „Digital Media“ gebündelt. Der Wachstumskurs der Gesellschaft soll sowohl auf Basis eines anhaltenden anorganischen Wachstums sowie durch den Ausbau des bestehenden Geschäftes fortgesetzt werden. Im Rahmen unserer Initial-Coverage-Studie haben wir ein Kursziel von 1,90 € je Aktie ermittelt und vergeben das Rating KAUFEN..

News im Fokus

Vonovia SE: Erfolgreiches Pflichtangebot - Vonovia wird nach Settlement 94 Prozent der Hembla-Aktien halten (News mit Zusatzmaterial)

10. Dezember 2019, 16:06

Aktuelle Research-Studie

amalphi AG

Original-Research: amalphi AG (von Sphene Capital GmbH): Buy

11. Dezember 2019